Stockscreener 앱 받기
2.01
2.90%
-0.06
시장 영업 전:
2.04
0.03
+1.49%
전일 마감가:
$2.07
열려 있는:
$2.14
하루 거래량:
450.51K
Relative Volume:
0.47
시가총액:
$43.96M
수익:
$1.38M
순이익/손실:
$-179.05M
주가수익비율:
-0.3274
EPS:
-6.14
순현금흐름:
$-155.03M
1주 성능:
-2.90%
1개월 성능:
+17.54%
6개월 성능:
+13.56%
1년 성능:
+390.36%
1일 변동 폭
$1.98
$2.1731
1주일 범위
$1.98
$2.30
52주 변동 폭
$0.16
$8.08
바이오엑셀 테라퓨틱스 Stock (BTAI) Company Profile
명칭
Bioxcel Therapeutics Inc
전화
203-643-8060
주소
555 LONG WHARF DRIVE, NEW HAVEN, CT
BTAI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BTAI
Bioxcel Therapeutics Inc
|
2.01 | 45.27M | 1.38M | -179.05M | -155.03M | -6.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
바이오엑셀 테라퓨틱스 Stock (BTAI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-02-21 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-08-15 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2023-07-17 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-03-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-12-01 | 업그레이드 | Goldman | Sell → Neutral |
| 2022-07-07 | 개시 | Mizuho | Buy |
| 2022-04-06 | 재확인 | BofA Securities | Buy |
| 2021-11-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-04-09 | 개시 | Berenberg | Buy |
| 2021-02-01 | 개시 | UBS | Buy |
| 2020-10-30 | 개시 | Goldman | Buy |
| 2020-09-02 | 개시 | Jefferies | Buy |
| 2020-08-17 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-08 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-04 | 개시 | Guggenheim | Buy |
| 2020-04-01 | 개시 | BofA/Merrill | Buy |
| 2020-02-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-01-08 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-12 | 개시 | SunTrust | Buy |
모두보기
바이오엑셀 테라퓨틱스 주식(BTAI)의 최신 뉴스
BTAI: All proposals, including director elections and a reverse split amendment, were approved - TradingView — Track All Markets
Aug Decliners: What MACD trends signal for BioXcel Therapeutics Inc BX20 stockJuly 2025 Snapshot & Advanced Swing Trade Entry Alerts - moha.gov.vn
BioXcel Therapeutics (BTAI) price target decreased by 26.17% to 16.12 - MSN
Can BioXcel Therapeutics Inc. (BX20) stock sustain free cash flowQuarterly Growth Report & Weekly High Return Opportunities - Newser
What Analysts Think Is Changing The Story For BioXcel Therapeutics Now - Yahoo Finance
Can BioXcel Therapeutics Inc. stock beat analyst upgrades2025 Biggest Moves & Real-Time Sentiment Analysis - Newser
Is BioXcel Therapeutics Inc. (BX20) stock a fit for income portfoliosM&A Rumor & Fast Entry Momentum Alerts - Newser
Award-Winning Journalist Anjalee Khemlani to Host Virtual Roundtable with Leading Medical Experts to Discuss Latest Developments in Treating Acute Agitation Related to Neuropsychiatric Conditions - The Manila Times
Award-Winning Journalist Anjalee Khemlani to Host Virtual - GlobeNewswire
BioXcel Therapeutics (BTAI) hosts Dec. 8 virtual panel on at-home agitation treatment - Stock Titan
What is the fair value of BioXcel Therapeutics Inc. stock nowJuly 2025 Short Interest & Fast Moving Stock Watchlists - Newser
Is BioXcel Therapeutics Inc. (BX20) stock worth holding before Fed meeting2025 Winners & Losers & Technical Entry and Exit Tips - Newser
Growth Value: Will BioXcel Therapeutics Inc. stock see insider buyingSwing Trade & Stepwise Trade Signal Guides - moha.gov.vn
Can BioXcel Therapeutics Inc. stock resist market sell offsTrade Volume Report & Technical Pattern Alert System - BỘ NỘI VỤ
FDA Approves New Indication for BioXcel Therapeutics' Igalmi (BT - GuruFocus
Why BioXcel Therapeutics Inc. (BX20) stock could be next leaderMarket Volume Summary & AI Enhanced Trading Alerts - newser.com
Can BioXcel Therapeutics Inc. stock deliver consistent earnings growthEarnings Recap Summary & Consistent Return Investment Signals - newser.com
Is BioXcel Therapeutics Inc. stock attractive after correctionQuarterly Market Summary & Expert Approved Momentum Ideas - newser.com
Why BioXcel Therapeutics Inc. (BX20) stock is listed among top recommendationsEarnings Recap Summary & Fast Entry Momentum Trade Alerts - newser.com
Will BioXcel Therapeutics Inc. stock see PE expansionJuly 2025 Earnings & Long Hold Capital Preservation Tips - newser.com
Can BioXcel Therapeutics Inc. stock beat market expectations this quarterTrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com
BioXcel Therapeutics Inc. (BTAI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is BioXcel Therapeutics Inc. (BX20) stock vulnerable to rate hikesChart Signals & Daily Entry Point Alerts - newser.com
What dividend safety score for BioXcel Therapeutics Inc. stockEarnings Miss & Community Verified Trade Signals - newser.com
Looking at the Narrative for BioXcel Therapeutics After Fair Value Reset and Clinical Milestones - Yahoo Finance
Can you recover from losses in BioXcel Therapeutics Inc.Short Setup & Capital Efficient Trade Techniques - newser.com
Does BioXcel Therapeutics Inc. show high probability of reboundJuly 2025 Chart Watch & AI Forecasted Entry and Exit Points - newser.com
바이오엑셀 테라퓨틱스 (BTAI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):